A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆9-tetrahydrocannabinol (THC) by vaporisation
Open Access
- 16 October 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Pharmacology and Toxicology
- Vol. 15 (1), 58
- https://doi.org/10.1186/2050-6511-15-58
Abstract
Significant interest has emerged in the therapeutic and interactive effects of different cannabinoids. Cannabidiol (CBD) has been shown to have anxiolytic and antipsychotic effects with high doses administered orally. We report a series of studies conducted to determine the vaporisation efficiency of high doses of CBD, alone and in combination with ∆9-tetrahydrocannabinol (THC), to achieve faster onset effects in experimental and clinical trials and emulate smoked cannabis.Keywords
This publication has 22 references indexed in Scilit:
- Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid ProfilePLOS ONE, 2013
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophreniaTranslational Psychiatry, 2012
- Methods of the Pharmacological Imaging of the Cannabinoid System (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognitionInternational Journal of Methods in Psychiatric Research, 2011
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia PatientsNeuropsychopharmacology, 2011
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and PsychopathologyNeuropsychopharmacology, 2009
- Effect of intrapulmonary tetrahydrocannabinol administration in humansJournal of Psychopharmacology, 2008
- Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabisThe British Journal of Psychiatry, 2008
- Potency of Δ9–THC and Other Cannabinoids in Cannabis in England in 2005: Implications for Psychoactivity and Pharmacology*Journal of Forensic Sciences, 2008
- Evaluation of a vaporizing device (Volcano®) for the pulmonary administration of tetrahydrocannabinolJournal of Pharmaceutical Sciences, 2006
- Pharmacokinetics and Pharmacodynamics of CannabinoidsClinical Pharmacokinetics, 2003